Home > Healthcare > Medical Services > Lab Services > Egg Freezing and Embryo Banking Market

Egg Freezing and Embryo Banking Market Trends

Report ID: GMI11172
Published Date: Sep 2024
Report Format: PDF

Download Free Sample

Egg Freezing and Embryo Banking Market Trends

The egg freezing and embryo banking industry is expected to experience significant growth, driven by government initiatives. In Australia, the re-election of the Liberal and Nationals Government has expanded fertility treatment rebates to include egg freezing procedures and increased cycle numbers. As a result, Australian women opting for egg freezing can now claim a USD 2,000 rebate, following a USD 4 million expansion within the NSW Government's USD 80 million Affordable IVF Initiative. These initiative-taking measures are anticipated to boost market growth by making fertility preservation more accessible.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The egg freezing and embryo banking industry was valued at approximately USD 4.2 billion in 2023 and is projected to grow at a CAGR of 16.7% from 2024 to 2032, driven by societal trends and advancements in reproductive technologies.

The embryo banking segment was worth USD 2.7 billion in 2023, as delayed parenthood due to career aspirations and lifestyle choices is leading individuals to preserve their reproductive potential for future use.

North America egg freezing and embryo banking industry is poised to reach USD 7.4 billion by 2032, propelled by a rapidly aging population, technological advancements, heightened public awareness, and the rising acceptance of assisted reproductive technologies.

CCRM Fertility, Cryos International, Extend Fertility LLC, Genea Pty Limited, IVIRMA Global, Monash IVF Group, and New Hope IVF & Fertility Clinic among others.